Streptococcal and enterococcal bacteremia in patients with cancer

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
A AwadaJ Klastersky

Abstract

Eighty-two episodes of bacteremia due to streptococci (including the genus Enterococcus) in 78 patients hospitalized at Institut Jules Bordet between 1986 and 1988 were reviewed. The incidence ranged from 5.5 to 7.6 per 1,000 admissions (16% of all bacteremias). Enterococcus faecalis, Streptococcus sanguis, and Streptococcus mitis were the most prevalent isolates, followed by Streptococcus angionosus, Streptococcus salivarius, and large colony-forming beta-hemolytic species (A, B, C, and G). Twenty-one episodes were polymicrobial. One-half of the patients had solid tumors, and one-half had hematologic malignancies. Forty-two patients were neutropenic (less than 1,000 polymorphonuclear neutrophils/microL). Only 15 episodes were acquired outside the hospital, and 11 episodes were breakthrough bacteremias. Twenty patients died within 1 month of the onset of streptococcal bacteremia. Five patients, two of whom were neutropenic, had fatal adult respiratory distress syndrome. The source of bacteremia remained undetermined in 35.4% of the episodes; the oral mucous membrane and the gastrointestinal tract were the most frequently recognized associated sites of infection. No unexpected antimicrobial resistance was observed except in two ...Continue Reading

Citations

Sep 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·E CastagnolaC Viscoli
Nov 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J Klastersky
Jul 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·G CarregaA Garaventa
Sep 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J Klastersky
Nov 1, 1994·Intensive Care Medicine·R N Grüneberg, A P Wilson
Feb 1, 1994·European Journal of Pediatrics·J W GrayA D Pearson
May 20, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J C CorredoiraJ Varela
Jul 1, 1996·International Journal of Antimicrobial Agents·I IlavskaV Krcmery
Feb 12, 1998·Diagnostic Microbiology and Infectious Disease·M Tuohy, J A Washington
Mar 18, 2000·International Journal of Antimicrobial Agents·J L Shenep
Sep 8, 2001·Mediators of Inflammation·D MuhvićD Rukavina
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B A CollinR Ramphal
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·M J FerrándizA G De La Campa
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Luz BalsalobreAdela G de la Campa
Aug 14, 2001·Journal of Clinical Microbiology·P IdigorasC Poyart
Oct 3, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph S SolomkinUNKNOWN Infectious Diseases Society of America
Jan 1, 1993·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·D CoullioudC Lasset
Jul 1, 1995·Pediatric Hematology and Oncology·F RossettiL Zanesco
Mar 14, 2012·The Journal of Infection·Seong Yeon ParkYang Soo Kim
Jan 21, 2012·Gastroenterología y hepatología·Joaquín Campos FrancoArturo González Quintela
Jan 1, 1995·The Journal of Hospital Infection·B Durand-GasselinC Cordonnier
Feb 1, 1996·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Florence MoulinAntoine Andremont
Jan 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M. Carmen FariñasJesús González-Macías
Jun 1, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·E LautenbachP J Brennan
Oct 26, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M J KuehnertW R Jarvis
Nov 16, 2004·Arquivos De Gastroenterologia·Marcelo L RibeiroJosé Pedrazzoli
Jul 14, 1999·Journal of Dental Research·H L ByersD Beighton
Dec 18, 2001·Medical and Pediatric Oncology·M D van de WeteringH N Caron
Apr 29, 1999·Medical and Pediatric Oncology·G WehlF M Fink
Jul 2, 2018·BMJ Case Reports·Robert ThomasBrian Kwan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
P Y BochudP Francioli
Scandinavian Journal of Infectious Diseases
C Watanakunakorn, J Pantelakis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J CarratalaF Gudiol
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
R ManfrediF Chiodo
© 2022 Meta ULC. All rights reserved